ArticlePublic health challenges2023
COVID-19 vaccination in Nigeria: Challenges and recommendations for future vaccination initiatives.
Article in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Integrating routine immunization into COVID-19 vaccination improve coverage but could create equity issues: evidence from Niger State, Nigeria.BMC public health · 2025Article
- Two years of COVID-19 vaccination in Nigeria: a review of the current situation of the pandemic: a literature review.Annals of medicine and surgery (2012) · 2023Article
- COVID-19 vaccination in Nigeria: Challenges and recommendations for future vaccination initiatives.Public health challenges · 2023Article
- Integrating health intervention into existing program structure of the neglected tropical diseases: lessons learned from Yobe and Ebonyi states.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 vaccination program is the most extensive vaccination program held in Nigeria to date. As of September 21, 2022, more than 31 million people have been fully vaccinated which made up 15% of the entire population. Following the global COVID-19 vaccination goal, Nigeria was expected to vaccinate 40% of its population in 2021 and reach the 70% vaccination threshold before the end of 2022. Currently, Nigeria is nowhere near the global vaccination goal due to various challenges encountered by the program. Challenges such as distrust in government, poor cold-chain management, and poor communication during the onset of the program all contributed to the inability to attain the set goal. With the pledge of Global Alliance for Vaccines and Immunizations to extend the malaria vaccination program to other Sub-Saharan African countries after the success of the first dose vaccination in Ghana, Kenya, and Malawi and the recent reemergence of monkeypox virus in Africa which also requires vaccination to curtail its spread, it is important that Nigeria, in preparation for these vaccination programs, learn from some of the challenges that the COVID-19 vaccination program encountered and take actions to ensure greater success in future vaccination programs in the country. This paper aims to give an overview of the COVID-19 vaccination program in Nigeria, highlight the challenges encountered, and provide recommendations for better future vaccination initiatives in the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.